This application for a National Research and Demonstration Center in Thrombosis provides an integrated collaborative program of basic research in blood clotting biology, blood vessel structure and function, and the biology of the thrombolytic pathway. These studies are integrated with clinical studies which are aimed at evaluating the role of coagulation factors, platelet and blood vessel constituents in thrombosis. The evaluation of interventive therapy through both coumarin anticoagulation and thrombolytic therapy is also included. These basic and clinical studies are directly related to the demonstration/education aspects of the proposed centers which will relate basic and clinical experience of the center through demonstrations/education projects to the surrounding community hospital personnel of the Vermont/Northern New England region. In the latter regard we will establish community survey and eductional programs with respect to deep vein thrombosis and pulmonary embolism in an attempt to establish better noninvasive techniques for the diagnosis of thrombosis in Northern New England. The proposed center is highly interactive and extends from physical studies at the molecular level through investigation of clinical intervention in thrombosis to community hospital programs. The Center personnel will share the information provided by this concerted effort to understand and treat the thrombotic event. Information arising from clinical and community studies will be directly related to basic studies at the protein and cellular level associated with thrombosis. Conversely, the basic data obtained in the laboratory will be rapidly and readily applied at the community hospital level. The thrombosis center will provide the appropriate focus for this investigative and community interactive operation.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Specialized Center (P50)
Project #
5P50HL035058-04
Application #
3106756
Study Section
(SRC)
Project Start
1986-05-01
Project End
1991-04-30
Budget Start
1989-05-01
Budget End
1990-04-30
Support Year
4
Fiscal Year
1989
Total Cost
Indirect Cost
Name
University of Vermont & St Agric College
Department
Type
Schools of Medicine
DUNS #
066811191
City
Burlington
State
VT
Country
United States
Zip Code
05405
Tracy, R P; Rubin, D Z; Mann, K G et al. (1997) Thrombolytic therapy and proteolysis of factor V. J Am Coll Cardiol 30:716-24
Messier, T L; Wong, C Y; Bovill, E G et al. (1996) Factor X Stockton: a mild bleeding diathesis associated with an active site mutation in factor X. Blood Coagul Fibrinolysis 7:5-14
Howard, P R; Bovill, E G; Pike, J et al. (1994) Factor VII antigen levels in a healthy blood donor population. Thromb Haemost 72:21-7
Becker, R C; Terrin, M; Ross, R et al. (1994) Comparison of clinical outcomes for women and men after acute myocardial infarction. The Thrombolysis in Myocardial Infarction Investigators. Ann Intern Med 120:638-45
Church, W R; Messier, T L; Ouellette, L A et al. (1994) A kringle-specific monoclonal antibody. Hybridoma 13:423-9
Bovill, E G; Soll, R F; Lynch, M et al. (1993) Vitamin K1 metabolism and the production of des-carboxy prothrombin and protein C in the term and premature neonate. Blood 81:77-83
Krishnaswamy, S; Nesheim, M E; Pryzdial, E L et al. (1993) Assembly of prothrombinase complex. Methods Enzymol 222:260-80
Lawson, J H; Krishnaswamy, S; Butenas, S et al. (1993) Extrinsic pathway proteolytic activity. Methods Enzymol 222:177-95
Krishnaswamy, S; Field, K A; Edgington, T S et al. (1992) Role of the membrane surface in the activation of human coagulation factor X. J Biol Chem 267:26110-20
Taylor Jr, F B; Hoogendoorn, H; Chang, A C et al. (1992) Anticoagulant and fibrinolytic activities are promoted, not retarded, in vivo after thrombin generation in the presence of a monoclonal antibody that inhibits activation of protein C. Blood 79:1720-8

Showing the most recent 10 out of 108 publications